April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Tear Film Osmolarity in Patients Treated for Glaucoma or Ocular Hypertension
Author Affiliations & Notes
  • Antoine Labbe
    Ophthalmology-Natl Hosp, CHNO des Quinze-Vingts, Paris, France
    Vision Institute, INSERM U968, CNRS UMR 7210, UPMC UMR S 968 and UVSQ, Paris, France
  • Emmanuelle Brasnu
    Ophthalmology-Natl Hosp, CHNO des Quinze-Vingts, Paris, France
  • Charles Van Went
    Ophthalmology-Natl Hosp, CHNO des Quinze-Vingts, Paris, France
  • Ophélie Terry
    Ophthalmology-Natl Hosp, CHNO des Quinze-Vingts, Paris, France
  • Christophe Baudouin
    Ophthalmology-Natl Hosp, CHNO des Quinze-Vingts, Paris, France
    Vision Institute, INSERM U968, CNRS UMR 7210, UPMC UMR S 968 and UVSQ, Paris, France
  • Footnotes
    Commercial Relationships  Antoine Labbe, None; Emmanuelle Brasnu, None; Charles Van Went, None; Ophélie Terry, None; Christophe Baudouin, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 218. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Antoine Labbe, Emmanuelle Brasnu, Charles Van Went, Ophélie Terry, Christophe Baudouin; Tear Film Osmolarity in Patients Treated for Glaucoma or Ocular Hypertension. Invest. Ophthalmol. Vis. Sci. 2011;52(14):218.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To evaluate tear film osmolarity in patients treated with intraocular pressure-lowering medications.

 
Methods:
 

Forty patients treated for glaucoma or ocular hypertension (OHT) and followed at the Quinze-Vingts National Ophthalmology Hospital were consecutively recruited for the study. Each patient was asked to complete an evaluation of ocular surface disease (OSD) symptoms and underwent a complete evaluation of the ocular surface including tear film osmolarity, Schirmer test, tear film breakup time (TBUT) and, corneal and conjunctival staining. Demographic information and glaucoma treatment were obtained from patient’s medical records.

 
Results:
 

Twenty eight patients (70%) had chronic glaucoma and 12 (30%) had OHT. There were 20 women and 20 men with a mean ± SD age of 63.9 ± 10.8 years. Twenty four patients (60%) reported OSD symptoms according to the OSDI. Nineteen patients (47.5%) had a tear osmolarity ≤ 308 mOsms/L, 11 (27.5%) between 309-328 mOsms/L and 10 (25%) > 328 mOsms/L. According to Schirmer test, a tear deficiency was observed in 20 patients (50%). Twenty seven patients (67.5%) had an abnormal tear quality analyzed with tear breakup time (TBUT) and 16 patients (40%) showed positive staining using the Oxford schema. There was a statistically significant correlation between tear osmolarity and the number of molecules (r=0.409, p=0.009), the number of instillations (r=0.405, p=0.01) and the number of instillations of preserved eyedrops (r=0.629, p<0.0001). Using the multiple regression method, tear osmolarity remained significantly correlated to the number of instillations of preserved eyedrops (p=0,004). Tear osmolarity was significantly correlated to OSDI (r=0.486; p=0.002) and TBUT (r=-0.49; p=0.009).

 
Conclusions:
 

Tear osmolarity was increased in patients treated for glaucoma or OHT, particularly in those using multiple preserved eyedrops. The evaluation of the ocular surface of patients treated for glaucoma or OHT may benefit from such analysis and future trials for new intraocular pressure-lowering eyedrops should thus evaluate tear osmolarity.

 
Keywords: drug toxicity/drug effects • cornea: tears/tear film/dry eye • clinical (human) or epidemiologic studies: prevalence/incidence 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×